+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Long-term follow-up, neurological outcome and survival rate in 28 Nordic patients with glutaric aciduria type 1



Long-term follow-up, neurological outcome and survival rate in 28 Nordic patients with glutaric aciduria type 1



European Journal of Paediatric Neurology 8(3): 121-129



All 28 patients, 13 females and 15 males, with glutaric aciduria type 1 diagnosed between 1975 and 2001 in Denmark, Finland, Norway and Sweden were identified and studied retrospectively until 2001. Mass screening was not performed. Three were sibling cases. Prenatal enzymatic diagnosis performed in 11 pregnancies led to termination in one. The median follow-up time was 14 years. Six patients had died. At 10 years of age the cumulative survival rate was 89% and at 35 years 44%. The dominating neurological sign was dystonia in 20 and dyskinesia in 4. Three had only slight spastic signs and information was missing in one. The head circumference at birth was significantly larger than normal and increased significantly until 6 months of age. The onset was acute encephalopathic in 24 patients and insidious in 3. From the time of diagnosis, all patients but one were prescribed protein restriction and/or a diet low in lysine and tryptophan. Riboflavine and/or carnitine supplementation were given to 25. Neurological deficits did not improve on the offered treatment. Deterioration may have been averted by intense acute metabolic treatment in a few patients. Dystonia correlated significantly to absence of speech but not to cognitive function. Severe disability, including motor, cognitive and speech functions, correlated significantly with acute onset, dystonia and mortality, and weakly with a deteriorating course, but not with age at onset, diagnosis, or follow-up, nor to head size. Results from future population studies derived from mass screening will have to relate to clinical diagnostic series of the kind presented here.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 049491104

Download citation: RISBibTeXText

PMID: 15120683

DOI: 10.1016/j.ejpn.2003.12.007


Related references

Use of guidelines improves the neurological outcome in glutaric aciduria type I. Annals of Neurology 68(5): 743-752, 2010

The long-term treatment of a patient with type 1 diabetes mellitus and glutaric aciduria type 1: the effect of insulin. European Journal of Pediatrics 175(8): 1123-1128, 2016

Glutaric aciduria type I: outcome of patients with early- versus late-diagnosis. European Journal of Paediatric Neurology 17(4): 383-389, 2013

Sensitivity of free and total glutaric and 3-OH-glutaric acid measurements by stable isotope dilution-assays for the diagnosis of glutaric aciduria type 1. Journal of Inherited Metabolic Disease 20(Suppl. 1): 34, 1997

The clinical and radiological features of glutaric aciduria type one, L-2-hydroxyglutaric aciduria and Canavan disease Report of 34 patients. Journal of Inherited Metabolic Disease 21(Suppl. 2): 49, 1998

The effect of mild hypothermia and induced hypertension on long term survival rate and neurological outcome after asphyxial cardiac arrest in rats. Resuscitation 49(1): 73-82, 2001

Glutaric aciduria type I: outcome in the Republic of Ireland. Journal of Inherited Metabolic Disease 27(6): 917-920, 2004

Clinical outcome of glutaric aciduria type I in Russia. 2007

Glutaric aciduria type I: outcome following detection by newborn screening. Journal of Inherited Metabolic Disease 31(4): 503-507, 2008

Outcome of three cases of untreated maternal glutaric aciduria type I. European Journal of Pediatrics 167(5): 569-573, 2008

'Classical' organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: long-term outcome and effects of expanded newborn screening using tandem mass spectrometry. Journal of Inherited Metabolic Disease 29(2-3): 383-389, 2006

Glutaric aciduria type 1 with normal evolution: follow-up of one case until adult age. Neurologia 20(4): 189-193, 2005

Long-term outcome and short-term survival of patients with systemic lupus erythematosus after bacteraemia episodes: 6-yr follow-up. Rheumatology 47(9): 1352-1357, 2008

Newborn screening for glutaric aciduria type I in Victoria: treatment and outcome. Molecular Genetics and Metabolism 94(3): 287-291, 2008

Suprasellar meningiomas--neurological and visual outcome at long-term follow-up in a homogeneous series of patients treated microsurgically. Acta Neurochirurgica 140(12): 1231-1238, 1998